By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Caliper Life Sciences today reported preliminary fourth-quarter revenue of approximately $36 million and preliminary full-year revenue of $123.5 million.

The preliminary results reflect a 4 percent dip from $37.7 million in the fourth quarter of 2009 and a 5 percent decrease in annual revenues compared to 2009. The company said that organic revenues grew 10 percent year-over-year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.